Both the successful pro-differentiating therapy currently used against APL [8] and the results shown previously were encouraging to test whether the chemical inhibition of SHP1 and SHP2 could trigger the differentiation of non-promyelocytic leukemic cells. Here, PTPN11 is linked to acute promyelocytic leukemia.